AKT1 and sarcoma: These pathways include the use of phosphatidylinositol 3-kinase (PI3K)–phosphoinositide-dependent kinase (PDK)–protein kinase B (AKT) and the rat sarcoma (RAS)−extracellular signal-regulated kinase (ERK).